Homepage
Medication Guide
How to Use Elafibranor
Elafibranor is a peroxisome proliferator-activated receptor (PPAR) agonist. Approved in the United States in 2024 for the treatment of primary biliary cholangitis (PBC), it is indicated for use in com...
501
Monday, September 15th, 2025, 15:12
How Effective is Vibegron in Treatment?
Vibegron is a selective β-3 adrenergic receptor agonist that was first approved for marketing in the United States in 2020. As an innovative drug for the treatment of overactive bladder (OAB), it prov...
502
Monday, September 15th, 2025, 14:56
Precautions for Vibegron Administration
Vibegron is a selective β3-adrenergic receptor agonist. It was first approved in the United States in 2020 for the treatment of overactive bladder (OAB) in adults. As a novel drug for OAB treatment, V...
501
Monday, September 15th, 2025, 14:51
How to Use Vibegron (Vibegron)
Vibegron is a selective β3-adrenergic receptor agonist. Approved in 2020, it is used for the treatment of overactive bladder (OAB) in adults, with symptoms including urge urinary incontinence, urgency...
503
Monday, September 15th, 2025, 14:33
Indications of Vibegron (Vibegron)
Vibegron is a selective β3-adrenergic receptor agonist developed by Urovant Sciences. It was first approved for marketing in the United States in 2020. As an innovative drug, it provides a new treatme...
502
Monday, September 15th, 2025, 14:17
Precautions for Administration of Datopotamab (Datroway)
Datopotamab (Datroway) is a Trop-2-targeted antibody-drug conjugate (ADC). It was first approved in the United States in 2025 for the treatment of adult patients with unresectable or metastatic hormon...
504
Monday, September 15th, 2025, 13:47
How to Use Datopotamab (Datroway)
Datopotamab (Datroway) is a Trop-2-targeted antibody-drug conjugate (ADC). It was approved in the United States in 2025 for the treatment of HR-positive, HER2-negative advanced breast cancer.How to Us...
501
Monday, September 15th, 2025, 13:40
Indications of Datopotamab (Datroway)
Datopotamab (Datroway) is a novel Trop-2-directed antibody-drug conjugate (ADC) linked to a topoisomerase inhibitor. Developed by Daiichi Sankyo Co., Ltd., it was first approved for marketing in the U...
504
Monday, September 15th, 2025, 13:27
How to Use Avelumab (Bavencio)
Avelumab (Bavencio) is a programmed death ligand-1 (PD-L1) blocking antibody, indicated for the treatment of adult and pediatric patients aged 12 years and older with metastatic Merkel cell carcinoma ...
505
Friday, September 12th, 2025, 15:10
Indications of Avelumab (Bavencio)
Avelumab (Bavencio) is a programmed death ligand-1 (PD-L1) blocking antibody, first approved for marketing by the U.S. FDA in 2017. As an immune checkpoint inhibitor, it activates the immune system to...
502
Friday, September 12th, 2025, 15:05
96 / 186
1852 in total
Departments
Oncology Hematology Immunology Hepatology Endocrinology Pulmonology Neurology Cardiology Gastroenterology Dermatology
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
haiousales@gmail.com
Welcome To Consult
Seagull Pharmacy.,Ltd All rights reserved